Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program
about
Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utilityLower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell traitDonor parity no longer a barrier for female-to-male hematopoietic stem cell transplantation.Protecting the Health and Safety of Cell and Tissue DonorsHigh-dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 casesAnalysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersRecovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201G-CSF in Healthy Allogeneic Stem Cell Donors.Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.Management of psychiatric complications in unrelated donor before unrelated peripheral hematopoietic stem cell collections.Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim.A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification-A Case Study on Sickle Cell Disease.Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.A review of the haematopoietic stem cell donation experience: is there room for improvement?A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation.Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors.Eighteen years experience of granulocyte donations-acceptable donor safety?The devil is in the details: confidentiality challenges in the age of genetics.Children as hematopoietic cell donors in research: when is it approvable?Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis.The Stem Cell Club: a model for unrelated stem cell donor recruitment.Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation.Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation.Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield.Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia.Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors-Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses
P2860
Q27012881-BE4064B8-E62A-4F6F-A4F6-E1629BFB8F78Q33718833-2944A8C2-9A27-4DF0-9745-E2971C188454Q33819995-48899BD1-1D7B-4DD7-B6E3-4018990AA5F2Q33880244-4002972D-5443-418E-9017-A845E7582092Q34352707-6A2C31C3-DB53-473B-A254-67E671B70861Q35551560-5B39F837-5FF8-4971-8160-CF5D50717DE2Q35870167-85B24047-930A-4D77-93CC-8F287790235EQ36055063-5C014347-48C5-4E36-86B2-CEA211216E73Q36902128-3E0C9FEB-695E-48BC-AA93-8826299EDAA7Q37180718-646A102A-9321-4EAA-9167-8E344C0D643FQ37237916-BE0482CC-2521-4945-B540-5103A65B3FCEQ37377933-69F557CF-8FFC-4BDA-997C-94C6A1187005Q37508110-68ED7CF0-FB74-4F48-B8C3-E7D6C1FE1141Q37573766-2F8F79EC-A69B-4DE7-A16E-A76E41D9D6A2Q37606891-62284D42-815A-4770-B037-F58C84374CF9Q37689822-B05F22E4-4A38-48FC-A39E-4A248EC34E36Q37689999-D12DBC4F-AC60-41BC-BFAB-27275AC59574Q38181958-565C5E5D-E0F3-4B9A-A7BD-59DA6AA60751Q38323097-9F91729A-12FF-49E0-8B3B-001E9E1DC868Q38832166-03C67698-E63A-4562-807E-5DE6DC4C07FDQ39186228-E7DE3CFB-33AF-4F8B-B2A0-F68913B851D1Q39385304-40BF7124-EE69-471F-B1BB-A70637E9CE03Q39972636-79BAF0DD-2848-41B4-8A08-BEE6AA20FFCAQ40727125-83D71D12-F540-4AA4-9F01-BCD5F39D8589Q41577983-9C7095B4-8892-4600-860C-67FB24E4C92EQ45300898-65F08BCB-8B11-4EED-B215-25359FCF2541Q46832046-38DA01F5-1FEB-4482-8943-E40C81B411AFQ46900519-1C84A782-DC18-4B8F-8459-776A3AE51813Q47133453-6F82A45B-35C2-487A-8ABD-7FE67CED1859Q47928869-36A40DFB-942B-4DD6-B02D-4041FDEB94E5Q47953542-C80D36A3-0228-4A2E-A907-C5C9787A4013Q48192483-4D687A8C-F13E-4EB8-9B78-3AD8FB55A00CQ48574957-59FF2711-9ED5-4269-ACB0-EAE7C086F485Q50463607-9D41AF86-F8D7-4785-AF9C-E9E67701FA78Q53091868-D6A7A541-F74C-4B07-8FB2-82C687FA1323Q53106181-D77F6E42-3124-44B7-9C73-FC72C93B9E8CQ53169108-86EAECDC-5F86-41C1-80B1-D2A09B60E6BEQ54518187-DA7619CF-F671-477E-AE28-78D7C4C81FDCQ59138311-E2808CDB-02A4-4D72-AE7B-2E28D16F5EDD
P2860
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Acute toxicities of unrelated ...... National Marrow Donor Program
@ast
Acute toxicities of unrelated ...... National Marrow Donor Program
@en
type
label
Acute toxicities of unrelated ...... National Marrow Donor Program
@ast
Acute toxicities of unrelated ...... National Marrow Donor Program
@en
prefLabel
Acute toxicities of unrelated ...... National Marrow Donor Program
@ast
Acute toxicities of unrelated ...... National Marrow Donor Program
@en
P2093
P2860
P1433
P1476
Acute toxicities of unrelated ...... National Marrow Donor Program
@en
P2093
Alison W Loren
Angela M Lopez
Brent R Logan
Bronwen E Shaw
David F Stroncek
Dennis L Confer
Dipnarine Maharaj
Edmund K Waller
John E Levine
John P Miller
P2860
P304
P356
10.1182/BLOOD-2012-03-417667
P407
P577
2012-10-29T00:00:00Z